Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial

Author:

Jagannathan Prasanna,Chew Kara W.,Giganti Mark J.,Hughes Michael D.,Moser Carlee,Main Mark J.,Monk Phillip D.,Javan Arzhang Cyrus,Li Jonathan Z.,Fletcher Courtney V.,McCarthy Caitlyn,Wohl David A.,Daar Eric S.,Eron Joseph J.,Currier Judith S.,Singh Upinder,Smith Davey M.,Fischer WilliamORCID,Chew Kara,Smith David (Davey),Daar Eric,Wohl David,Currier Judith,Eron Joseph,Javan Arzhang Cyrus,Hughes Michael,Moser Carlee,Giganti Mark,Ritz Justin,Hosey Lara,Roa Jhoanna,Patel Nilam,Colsh Kelly,Rwakazina Irene,Beck Justine,Sieg Scott,Li Jonathan,Fletcher Courtney,Fischer William,Evering Teresa,Ignacio Rachel Bender,Cardoso Sandra,Corado Katya,Jagannathan Prasanna,Jilg Nikolaus,Perelson Alan,Pillay Sandy,Riviere Cynthia,Singh Upinder,Taiwo Babafemi,Gottesman Joan,Newell Matthew,Pedersen Susan,Dragavon Joan,Jennings Cheryl,Greenfelder Brian,Murtaugh William,Kosmyna Jan,Gapara Morgan,Shahkolahi Akbar,Main Mark J.,Pierone Gerald,Elliott Juliana,Jacobson Jeffrey,Hojat Leila,Pasternak Julie,Berardi Jonathan,Arar Celine,Bukhman Yevgeniy,Jain Manish,Bukhman Eugene,Shaik Sadia,Hatlen Timothy,Dooley Kelly,Becker Becky,Wilkins Adaliah,Pérez Jose,Roman Eloy,Fernández Heriberto,Hoover Keila,Renfroe James,Weldon Mauney,Bougher Genei,Malvestutto Carlos,Harber Heather,Cicarella Robyn,Neytman Gene,Herman Jack,Herman Craig,Aziz Mariam,Swiatek Joan,Pathak Divya,Choudhary Madhu,Sullivano Jennifer,Osiyemi Olayemi,Izquierdo Myriam,Torna Odelsey,Khodabakhshian Aleen,Fortier Samantha,Benson Constance,Hendrickx Steven,Ramirez Rosemarie,Luetkemeyer Anne,Hendler Suzanne,Dentoni-Lasofsky Dennis,Castro Mario,Spikes Leslie,Hall Chase,Oakes Jonathan,Loftis Amy James,Tebas Pablo,Short William,McGuffin Sarah,Jonsson Chris,Presti Rachel,Haile Alem

Funder

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

General Medicine

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3